Mary G. Johlfs

An Engineered Human IgG1 Antibody with Longer Serum Half-Life

Paul R. Hinton, Joanna M. Xiong, Mary G. Johlfs et al. · The Journal of Immunology · 2006 · 279 citations · Full text

Immunology, Cell Death, Immunotherapy +17

Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates

Paul R. Hinton, Mary G. Johlfs, Joanna M. Xiong et al. · Journal of Biological Chemistry · 2004 · 271 citations · Full text

Protein Kinase G Type Iα Activity in Human Ovarian Cancer Cells Significantly Contributes to Enhanced Src Activation and DNA Synthesis/Cell Proliferation

Elaine Lai‐Han Leung, Janica C. Wong, Mary G. Johlfs et al. · Molecular Cancer Research · 2010 · 73 citations

Chemoprevention Strategy, Nitric Oxide, Apoptosis +16

Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells

Germana Rappa, Javier Mercapide, Fabio Anzanello et al. · Experimental Cell Research · 2013 · 55 citations · Full text

Cancer Research, Medicine, Photocarcinogenesis +10

Protein kinase G type-Iα phosphorylates the apoptosis-regulating protein Bad at serine 155 and protects against apoptosis in N1E-115 cells

Mary G. Johlfs, Ronald R. Fiscus · Neurochemistry International · 2010 · 27 citations

N1e-115 Cells, Signal Transduction, Molecular Physiology +11